Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF

Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference

Liraglutide shows superior cardiometabolic benefits than

HFpEF Is the Substrate for Stroke in Obesity and Diabetes

Rana Assaly على LinkedIn: #hfpef #diastolic_dysfunction

Elafibranor improves diet-induced nonalcoholic steatohepatitis

نشر Rana Assaly على LinkedIn

Immunometabolic mechanisms of heart failure with preserved

Heart Failure With Preserved Ejection Fraction and Diabetes: JACC

François Briand en LinkedIn: #nash #fibrosis #obesity

Heart Failure With Preserved Ejection Fraction